Compare BLCO & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | GBTG |
|---|---|---|
| Founded | 1853 | 2014 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | 2022 | 2020 |
| Metric | BLCO | GBTG |
|---|---|---|
| Price | $15.03 | $9.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $18.45 | $8.92 |
| AVG Volume (30 Days) | 404.4K | ★ 3.2M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 173.33 |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $5,101,000,000.00 | $2,718,000,000.00 |
| Revenue This Year | $8.65 | $21.78 |
| Revenue Next Year | $5.59 | $4.29 |
| P/E Ratio | ★ N/A | $93.60 |
| Revenue Growth | 6.47 | ★ 12.17 |
| 52 Week Low | $11.44 | $4.96 |
| 52 Week High | $18.92 | $9.54 |
| Indicator | BLCO | GBTG |
|---|---|---|
| Relative Strength Index (RSI) | 40.00 | 73.34 |
| Support Level | $14.55 | $9.33 |
| Resistance Level | $15.67 | $9.49 |
| Average True Range (ATR) | 0.38 | 0.05 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 25.91 | 23.68 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.